Maximizing the Success of Initial Parathyroid Surgery

Chapter
First Online:

Abstract

Although most patients with primary hyperparathyroidism can anticipate being cured after a single procedure, the sometimes challenging nature of parathyroid disease ensures that operative failures cannot be completely eliminated. Surgeons should understand the potential causes of failed parathyroid surgery and be aware of possible pitfalls in the diagnosis and management of surgical parathyroid disease. Armed with a thorough understanding of parathyroid pathology, and with careful preoperative assessment, meticulous operative planning and execution, and thoughtful integration of surgical adjuncts, surgeons are well positioned to maximize the likelihood of successful initial parathyroid surgery.

Keywords

Parathyroidectomy Reoperative Surgical success Parathyroid surgery Operative failure Reoperative parathyroidectomy Reoperative parathyroid surgery 
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Khan AA, Bilezikian JP, Potts JT Jr. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab. 2009;94(2):333–4.CrossRefPubMedGoogle Scholar
  2. 2.
    Terris DJ, Stack BC Jr, Gourin CG. Contemporary parathyroidectomy: exploiting technology. Am J Otolaryngol. 2007;28(6):408–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Karakas E, Schneider R, Rothmund M, Bartsch DK, Schlosser K. Initial surgery for benign primary hyperparathyroidism: an analysis of 1,300 patients in a teaching hospital. World J Surg. 2014;38(8):2011–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Bieglmayer C, Prager G, Niederle B. Kinetic analyses of parathyroid hormone clearance as measured by three rapid immunoassays during parathyroidectomy. Clin Chem. 2002;48(10):1731–8.PubMedGoogle Scholar
  5. 5.
    Leiker AJ, Yen TW, Eastwood DC, et al. Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed. JAMA Surg. 2013;148(7):602–6.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Felsenfeld AJ, Rodríguez M, Aguilera-Tejero E. Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2007;2(6):1283–305.CrossRefPubMedGoogle Scholar
  7. 7.
    Wallace LB, Parikh RT, Ross LV, et al. The phenotype of primary hyperparathyroidism with normal parathyroid hormone levels: how low can parathyroid hormone go? Surgery. 2011;150(6):1102–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. N Am J Med Sci. 2015;7(11):483–93.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Glendenning P, Gutteridge DH, Retallack RW, et al. High prevalence of normal total calcium and intact PTH in 60 patients with proven primary hyperparathyroidism: a challenge to current diagnostic criteria. Aust NZ J Med. 1998;28(2):173–8.Google Scholar
  10. 10.
    Eastell R, Brandi ML, Costa AG, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3570–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Carneiro-Pla D, Solorzano C. A summary of the new phenomenon of normocalcemic hyperparathyroidism and appropriate management. Curr Opin Oncol. 2012;24(1):42–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Shindo M, Lee JA, Lubitz CC, et al. The changing landscape of primary, secondary, and tertiary hyperparathyroidism: highlights from the American College of Surgeons panel, “What’s new for the surgeon caring for patients with hyperparathyroidism”. J Am Coll Surg. 2016;222(6):1240–50.CrossRefPubMedGoogle Scholar
  13. 13.
    Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism-a consensus report of the European society of endocrine surgeons (ESES). Langenbeck's Arch Surg. 2015;400(8):867–86.CrossRefGoogle Scholar
  14. 14.
    Bilezikian J, Potts J, Fuleihan G-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87(12):5353–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Christensen S, Nissen P, Vestergaard P, et al. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol. 2008;69:713–20.CrossRefGoogle Scholar
  16. 16.
    Varghese J, Rich T, Jimenez C. Benign familial hypocalciuric hypercalcemia. Endocr Pract. 2011;17(Suppl 1):13–7.Google Scholar
  17. 17.
    Wade TJ, Yen TW, Amin AL, Wang TS. Surgical management of normocalcemic primary hyperparathyroidism. World J Surg. 2012;36(4):761–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Udelsman R, Åkerström G, Biagini C, et al. The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3595–606.CrossRefPubMedGoogle Scholar
  19. 19.
    Bratucu MN, Garofil ND, Radu PA, et al. Measurement of quality of life after total parathyroidectomy in patients with secondary hyperparathyroidism and end stage renal disease. Chirurgia (Bucur). 2015;110(6):511–7.Google Scholar
  20. 20.
    Cruzado JM, Moreno P, Torregrosa JV, et al. A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol. 2016;27(8):2487–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop. J Clin Endocrinol Metab. 2014;99(10):3561–9.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med. 1992;33(10):1801–7.PubMedGoogle Scholar
  23. 23.
    Schenk WG III, Hanks JB, Smith PW. Surgeon-performed ultrasound for primary hyperparathyroidism. Am Surg. 2013;79(7):681–5.PubMedGoogle Scholar
  24. 24.
    Chazen JL, Gupta A, Dunning A, Phillips CD. Diagnostic accuracy of 4D-CT for parathyroid adenomas and hyperplasia. Am J Neuroradiol. 2012;33:429–33.CrossRefPubMedGoogle Scholar
  25. 25.
    Hinson AM, Lee DR, Hobbs BA, et al. Preoperative 4D CT localization of nonlocalizing parathyroid adenomas by ultrasound and SPECT-CT. Otolaryngol Head Neck Surg. 2015;153(5):775–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Singer MC, Pucar D, Mathew M, Terris DJ. Improved localization of sestamibi imaging at high-volume centers. Laryngoscope. 2013;123(1):298–301.CrossRefPubMedGoogle Scholar
  27. 27.
    Hetrakul N, Civelek AC, Stagg CA, Udelsman R. In vitro accumulation of technetium-99m-sestamibi in human parathyroid mitochondria. Surgery. 2001;130(6):1011–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Keane DF, Roberts G, Smith R, et al. Planar parathyroid localization scintigraphy: a comparison of subtraction and 1-, 2- and 3-h washout protocols. Nucl Med Commun. 2013;34(6):582–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Jofré J, González P, Massardo T, Zavala A. Optimal imaging time for delayed images in the diagnosis of abnormal parathyroid tissue with Tc-99m sestamibi. Clin Nucl Med. 1999;24(8):594–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Krausz Y, Shiloni E, Bocher M, et al. Diagnostic dilemmas in parathyroid scintigraphy. Clin Nucl Med. 2001;26(12):997–1001.CrossRefPubMedGoogle Scholar
  31. 31.
    Nagar S, Walker DD, Embia O, et al. A novel technique to improve the diagnostic yield of negative sestamibi scans. Surgery. 2014;156(3):584–90.CrossRefPubMedGoogle Scholar
  32. 32.
    Duke WS, Vernon HM, Terris DJ. Reoperative parathyroidectomy: overly descended superior adenoma. Otolaryngol Head Neck Surg. 2016;154(2):268–71.CrossRefPubMedGoogle Scholar
  33. 33.
    Wong KK, Fig LM, Gross MD, Dwamena BA. Parathyroid adenoma localization with 99m Tc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun. 2015;36(4):363–75.CrossRefPubMedGoogle Scholar
  34. 34.
    Untch BR, Adam MA, Scheri RP, et al. Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212(4):522–9.CrossRefPubMedGoogle Scholar
  35. 35.
    Kamaya A, Quon A, Jeffrey R. Sonography of the abnormal parathyroid gland. Ultrasound Q. 2006;22(4):253–62.CrossRefPubMedGoogle Scholar
  36. 36.
    Cheung K, Wang T, Farrokhyar F, et al. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19:577–83.CrossRefPubMedGoogle Scholar
  37. 37.
    Odronic SI, Reynolds JP, Chute DJ. Cytologic features of parathyroid fine-needle aspiration on ThinPrep preparations. Cancer Cytopathol. 2014;122(9):678–84.CrossRefPubMedGoogle Scholar
  38. 38.
    Bancos I, Grant CS, Nadeem S, et al. Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr Pract. 2012;18(4):441–9.CrossRefPubMedGoogle Scholar
  39. 39.
    Berber E, Parikh RT, Ballem N, et al. Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery. 2008;144(1):74–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Chandramohan A, Sathyakumar K, Irodi A, Abraham D, Paul MJ. Causes of discordant or negative ultrasound of parathyroid glands in treatment naïve patients with primary hyperparathyroidism. Eur J Radiol. 2012;81(12):3956–64.CrossRefPubMedGoogle Scholar
  41. 41.
    Duke WS, Bush CM, Singer MC, et al. Incision planning in thyroid compartment surgery: getting it perfect. Endocr Pract. 2015;21(2):107–14.CrossRefPubMedGoogle Scholar
  42. 42.
    Albuja-Cruz MB, Allan BJ, Parikh PP, Lew JI. Efficacy of localization studies and intraoperative parathormone monitoring in the surgical management of hyperfunctioning ectopic parathyroid glands. Surgery. 2013;154(3):453–60.CrossRefPubMedGoogle Scholar
  43. 43.
    Phitayakorn R, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg. 2006;191(3):418–23.CrossRefPubMedGoogle Scholar
  44. 44.
    Fancy T, Gallagher D, Hornig J. Surgical anatomy of the thyroid and parathyroid glands. Otolaryngol Clin N Am. 2010;43:221–7.CrossRefGoogle Scholar
  45. 45.
    Mohebati A, Shaha AR. Anatomy of the thyroid and parathyroid glands and neurovascular relations. Clin Anat. 2012;25:19–31.CrossRefPubMedGoogle Scholar
  46. 46.
    Wang C. The anatomic basis of parathyroid surgery. Ann Surg. 1976;183(3):271–5.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Gough I. Reoperative parathyroid surgery: the importance of ectopic location and multigland disease. ANZ J Surg. 2006;76(12):1048–50.CrossRefPubMedGoogle Scholar
  48. 48.
    Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013;37(1):102–6.CrossRefPubMedGoogle Scholar
  49. 49.
    Franz RC, Ungerer JP, du Toit SA. Selective intra-operative internal jugular venous sampling for rapid immunoradiometric assay of intact parathyroid hormone during parathyroid surgery. S Afr Med J. 1997;87(9):1156.PubMedGoogle Scholar
  50. 50.
    Ito F, Sippel R, Lederman J, Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg. 2007;245(6):959–63.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Ritter H, Milas M. Bilateral parathyroid exploration for hyperparathyroidism. Oper Tech Otolaryngol. 2009;20:44–53.CrossRefGoogle Scholar
  52. 52.
    Lorenz K, Nguyen-Thanh P, Dralle H. Unilateral open and minimally invasive procedures for primary hyperparathyroidism: a review of selective approaches. Langenbeck's Arch Surg. 2000;385(2):106–17.CrossRefGoogle Scholar
  53. 53.
    Barczyński M, Gołkowski F, Nawrot I. The current status of intraoperative iPTH assay in surgery for primary hyperparathyroidism. Gland Surg. 2015;4(1):36–43.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Lee JA, Inabnet WB III. The surgeon’s armamentarium to the surgical treatment of primary hyperparathyroidism. J Surg Oncol. 2005;89(3):130–5.CrossRefPubMedGoogle Scholar
  55. 55.
    Westerdahl J, Bergenfelz A. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg. 2007;246(6):976–80.CrossRefPubMedGoogle Scholar
  56. 56.
    Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbeck's Arch Surg. 2009;394(5):843–9.CrossRefGoogle Scholar
  57. 57.
    Adil E, Adil T, Fedok F, Kauffman G, Goldenberg D. Minimally invasive radioguided parathyroidectomy performed for primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2009;141(1):34–8.CrossRefPubMedGoogle Scholar
  58. 58.
    Noureldine SI, Gooi Z, Tufano RP. Minimally invasive parathyroid surgery. Gland Surg. 2015;4(5):410–9.PubMedPubMedCentralGoogle Scholar
  59. 59.
    Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012;214(3):260–9.CrossRefPubMedGoogle Scholar
  60. 60.
    Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL III. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003;134(6):973–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Lombardi CP, Raffaelli M, Traini E, et al. Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease. Langenbeck's Arch Surg. 2008;393(5):639–45.CrossRefGoogle Scholar
  62. 62.
    Johnson SJ. Changing clinicopathological practice in parathyroid disease. Histopathology. 2010;56(7):835–51.CrossRefPubMedGoogle Scholar
  63. 63.
    Farrag T, Weinberger P, Seybt M, Terris DJ. Point-of-care rapid intraoperative parathyroid hormone assay of needle aspirates from parathyroid tissue: a substitute for frozen sections. Am J Otolaryngol. 2011;32(6):574–7.CrossRefPubMedGoogle Scholar
  64. 64.
    Mazeh H, Kouniavsky G, Schneider DF, et al. Intrathyroidal parathyroid glands: small, but mighty (a Napoleon phenomenon). Surgery. 2012;152(6):1193–200.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of Otolaryngology, Division of EndocrinologyAugusta University Thyroid and Parathyroid Center, Augusta UniversityAugustaUSA

Personalised recommendations